首页> 外文期刊>Neuropsychopharmacology >Blockade by the Cannabinoid CB1 Receptor Antagonist, Rimonabant (SR141716), of the Potentiation by Quinelorane of Food-Primed Reinstatement of Food-Seeking Behavior
【24h】

Blockade by the Cannabinoid CB1 Receptor Antagonist, Rimonabant (SR141716), of the Potentiation by Quinelorane of Food-Primed Reinstatement of Food-Seeking Behavior

机译:大麻素CB1受体拮抗剂Rimonabant(SR141716)对喹诺罗酮增强以食物为主导的寻食行为的增强作用

获取原文
获取外文期刊封面目录资料

摘要

It has been shown previously that the selective cannabinoid CB1 receptor antagonist, rimonabant (SR141716), reduced the intake of palatable food as well as the self-administration of several drugs of abuse, suggesting that endocannabinoid systems play a role in brain reward function. The present study investigated whether a cannabinoid step was involved in food-seeking behavior induced by explicit stimuli, using an operant reinstatement procedure in rats. Experimental sessions consisted of a 15-min food rewarded period, followed by a 45-min extinction period. Rimonabant did not affect the response reinstatement induced by noncontingent delivery of food pellets, but prevented (0.03–0.3 mg/kg) the potentiation by quinelorane, a dopamine D3 receptor-preferring agonist, of food-seeking behavior. A possible link between cannabinoid processes and D3- and/or D2-mediated dopaminergic transmission was further investigated by studying Fos protein expression in cortico-limbic structures in D3 (D3-/-) and D2 (D2-/-) knockout mice. Rimonabant (10 mg/kg) increased Fos immunoreactivity in the prefrontal cortex (pFCortex) and in the shell but not the core of the nucleus accumbens (NAcc). Fos induction by this dose of rimonabant was not seen in mice lacking CB1 receptors, providing clear evidence for the involvement of CB1 receptors. In the NAcc shell, the effect of rimonabant was suppressed in D3-/-, but remained unchanged in D2-/- mice. In contrast, Fos expression by rimonabant in the pFCortex was impervious to D2 or D3 receptor deletion. In conclusion, these data indicate first that rimonabant prevented the enhancement by quinelorane of the appetitive value of food pellets unexpectedly delivered during extinction and second that rimonabant effects might involve D3 receptor-mediated processes. Overall, these results are consistent with the notion that endocannabinoid functions control brain reward processes and in particular the capacity of explicit stimuli to precipitate food-seeking behavior.
机译:先前已证明选择性大麻素CB1受体拮抗剂利莫那班(SR141716)减少了可口食物的摄入以及几种滥用药物的自用,这表明内源性大麻素系统在大脑的奖励功能中起作用。本研究使用操作性恢复程序在大鼠中调查了大麻步骤是否参与由明确刺激诱导的觅食行为。实验阶段包括15分钟的食物奖励期和45分钟的灭绝期。利莫那班不会影响非连续性食物颗粒递送所引起的反应恢复,但会阻止(0.03-0.3 mg / kg)喹诺罗烷(多巴胺D3受体优先激动剂)对食物寻求行为的增强作用。通过研究D3(D3-/-)和D2(D2-/-)敲除小鼠的皮质-边缘结构中的Fos蛋白表达,进一步研究了大麻素过程与D3和/或D2介导的多巴胺能传递之间的可能联系。利莫那班(10 mg / kg)增加了前额叶皮层(pFCortex)和外壳中的Fos免疫反应性,但没有伏伏核(NAcc)的核心。在缺乏CB1受体的小鼠中未观察到这种剂量的利莫那班诱导的Fos诱导,为CB1受体的参与提供了明确的证据。在NAcc壳中,利莫那班的作用在D3-/-中被抑制,但在D2-/-小鼠中保持不变。相反,利莫那班在pFCortex中表达的Fos不能穿透D2或D3受体。总而言之,这些数据表明,利莫那班防止了灭绝过程中意外释放的食品颗粒的奎尼罗烷的食用价值增强,其次,利莫那班的作用可能涉及D3受体介导的过程。总的来说,这些结果与内源性大麻素功能控制大脑奖赏过程,特别是明确刺激刺激食物寻求行为的能力的观点相一致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号